Biotech giant Gilead Sciences, which produces the drug, began distributing it on a compassionate-use basis in January 2020. Compassionate use is a form of expanded access to a drug, describing “the individual patient use of an investigational medicinal product outside of a clinical trial that is intended to treat a serious or life-threatening condition.”



Read more…